Comparison of sulfadoxine-pyrimethamine, unsupervised artemether- lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: A randomized effectiveness noninferiority trial

Journal of Infectious Diseases

Volumn 200, Issue 1, 2009, Pages 57-65

  Faucher, Jean François ^a,e   Aubouy, Agnès ^a   Adeothy, Adicat ^b   Cottrell, Gilles ^a   Doritchamou, Justin ^a   Gourmel, Bernard ^f   Houzé, Pascal ^f   Kossou, Hortense ^c   Amedome, Hyacinthe ^d   Massougbodji, Achille ^b   Cot, Michel ^g   Deloron, Philippe ^g  

^a Mother and Child Health in the Tropics Research Unit   (Benin)

^b Department of Parasitology   (Benin)

^c National Malaria Control Programme   (Benin)

^d Ministry of Public Health   (Benin)

^e UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; COARSUCAM; FANSIDAR; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; ASTHENIA; BENIN; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; COUGHING; DEATH; DRUG EFFICACY; DRUG FORMULATION; DRUG TREATMENT FAILURE; FEMALE; FEVER; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALAISE; MALARIA FALCIPARUM; MALE; MOUTH ULCER; PARASITEMIA; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REINFECTION; SIDE EFFECT; VOMITING;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; BENIN; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; POLYMERASE CHAIN REACTION; PYRIMETHAMINE; SULFADOXINE;

EID: 67650667771     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599378     Document Type: Article

References (28)

1. Aubouy A, Fievet N, Bertin G, et al. Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin. Trop Med Int Health 2007; 12:886-94.
2. Nahum A, Erhart A, Gazard D, et al. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa. Malar J 2007; 6:170.
3. de Radiguès X, Diallo KI, Diallo M, et al. Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali. Trans R Soc Trop Med Hyg 2006; 100:1013-8.
4. Kofoed PE, Rodrigues A, Aaby P, Rombo L. Continued efficacy of sulfadoxine-pyrimethamine as second line treatment for malaria in children in Guinea-Bissau. Acta Trop 2006; 100:213-7.
5. Zongo I, Dorsey G, Rouamba N, et al. Amodiaquine, sulfadoxinepyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. Am J Trop Med Hyg 2005; 73:826-32.
6. Barnes KI, Durrheim DN, Little F, et al. Effect of artemether- lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2005; 2:e330.
7. Bhattarai A, Ali AS, Kachur SP, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 2007; 4:e309.
8. Mutabingwa TK, Anthony D, Heller A, et al. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 2005; 365:1474-80.
9. Koram KA, Abuaku B, Duah N, Quashie N. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop 2005; 95: 194-203.
10. Mockenhaupt FP, Ehrhardt S, Dzisi SY, et al. A randomized, placebocontrolled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Trop Med Int Health 2005; 10:512-20.
11. World Health Organization (WHO). Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated malaria, Geneva: WHO, 2003.
12. Blessbom D, Römsing S, Annerberg A, et al. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. J Pharm Biomed Anal 2007; 45:282-7.
13. Gitau EN, Muchohi SN, Ogutu BR, et al. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 799:173-7.
14. Plowe CV, Djimde A, Bouare M, et al. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 1995; 52:565-8.
15. Aubouy A, Bakary M, Keundjian A, et al. Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Antimicrob Agents Chemother 2003; 47:231-7.
16. Rwagacondo CE, Niyitegeka F, Sarushi J, et al. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. Am J Trop Med Hyg 2003; 68:743-7.
17. Briand V, Cottrell G, Massougbodji A, Cot M. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J 2007; 6:160.
18. O'Meara WP, JG Breman, FE McKenzie. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar J 2005; 4:33.
19. Dorsey G, Staedke S, Clark TD, Njama-Meya D, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 2007; 297:2210-9.
20. Bukirwa H, Yeka A, Kamya MR, Talisuna A, et al. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials 2006; 1:e7.
21. Mårtensson A, Strömberg J, Sisowath C, et al. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis 2005; 41:1079-86.
22. Owusu-Agyei S, Asante KP, Ruth Owusu R, et al. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. PLoS ONE 2008; 3:e2530.
23. Adjei GO, Kurtzhals JA, Rodrigues OP, et al. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year followup. Malar J 2008; 7:127.
24. Checchi F, Piola P, Fogg C, et al. Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malar J 2006; 5:59.
25. Hietala SF, Bhattarai A, Msellem M, et al. Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria. J Pharmacokinet Pharmacodyn 2007; 34:669-86.
26. Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine: clinical implications. Clin Pharmacokinet 1996; 30: 263-99.
27. Orrell C, Little F, Smith P, et al Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. Eur J Clin Pharmacol 2008; 64:683-90.
28. Piola P, Fogg C, Bajunirwe F, et al. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet 2005; 365:1467-73.